Silibinin, a novel chemokine receptor type 4 antagonist, inhibits chemokine ligand 12-induced migration in breast cancer cells.
| Image |  |
|---|---|
| Description | scientific article published on 30 July 2014 |
| Author/s |
author: Mary Miu-Yee Waye Jian-Shu Hu Yan Wang |
| Publication date | July 30, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |